The main drivers for Vedanta's positive outlook cited by analysts include strong performance in the aluminium, zinc, and oil ...

Following the Q3 earnings announcement, brokerages offered mixed views on the IndusInd Bank stock. Among the 50 analysts covering IndusInd Bank, 37 have a 'Buy' rating, 12 recommend 'Hold', while one ...

Leading brokerage CLSA is bullish on the stock as it said that the commissioning of projects is crucial for earnings ...

Alphabet Inc.'s strong Q3 results and leadership in digital advertising, AI, and cloud position it for double-digit earnings ...

CNBC reviews Mutual of Omaha life insurance, which including term life policies up to age 80 and final expense coverage to age 85.

Tesla appears overvalued again and recommend trimming TSLA due to overly optimistic projections around future products. Click ...

Premium bonds cost more than their face value. Find out how these bonds work and see if they're a worthwhile investment.

For some, the Ford Bronco is one of the best SUVs to buy. However, the rugged off-road vehicle has seen a decline in sales. It’s also true that there have been car recalls for the Bronco, and many ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Nationwide is the best life insurance provider for diabetics, according to Investopedia research. John Hancock and State Farm also made our list. Compare coverage and cost information among the best ...

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...

Needham analyst Ryan MacDonald has reiterated their bullish stance on COUR stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...